Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging.

Detection of Antibodies against Human and Plant Aquaporins in Patients with Multiple Sclerosis. Autoimmune Dis (2015) 0.75

CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics. J Immunol (2016) 0.75

Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57

The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03

Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol (1993) 2.23

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol (2010) 1.99

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol (2009) 1.88

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med (2007) 1.61

Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci (2006) 1.52

Neuromyelitis optica. Semin Neurol (2002) 1.48

Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol (2009) 1.31

Interferon-beta(1b) treatment in neuromyelitis optica. Eur Neurol (2009) 1.16

NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers (2006) 1.14

Have we finally identified an autoimmune demyelinating disease? Ann Neurol (2009) 0.82

Neuromyelitis optica: current concepts. Front Biosci (2004) 0.80